DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Chalmers JD, Haworth CS, Metersky ML. et al; WILLOW Investigators.
Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis.
N Engl J Med 2020;
383 (22) 2127-2137
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.